Barrington analyst Alexander Paris reiterated a Buy rating on Carriage Services (CSV – Research Report) today and set a price target of $60.00. The company’s shares closed last Friday at $50.51.
According to TipRanks.com, Paris is a 5-star analyst with an average return of 18.2% and a 55.0% success rate. Paris covers the Services sector, focusing on stocks such as Universal Technical Institute, Adtalem Global Education, and Franklin Covey Company.
Carriage Services has an analyst consensus of Strong Buy, with a price target consensus of $71.00.
See Insiders’ Hot Stocks on TipRanks >>
Based on Carriage Services’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $95.04 million and net profit of $13.05 million. In comparison, last year the company earned revenue of $84.39 million and had a net profit of $5.53 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Carriage Services, Inc. provides funeral and cemetery services and products in the United States of America. It operates through the following segments: Funeral Home Operations and Cemetery Operations. The Funeral Home Operations segment offers a complete suite of services to meet families funeral needs, including consultation, the removal and preparation of remains, the sale of caskets and related funeral merchandise, the use of funeral homes for visitation and remembrance services and transportation services. The Cemetery Operations segment provide interment rights and related merchandise, such as markers and outer burial containers. The company was founded by Melvin C. Payne in 1991 and is headquartered in Houston, TX.
Read More on CSV:
- Analysts Are Bullish on Top Financial Stocks: WP Carey & Co (WPC), Focus Financial Partners (FOCS)
- Excellent Ecommerce: Shopify Upgraded Before Earnings
- Noble Financial Thinks Kratos Defense’s Stock is Going to Recover
- Soros Reveals $1B Stake in Rivian – Report
- Neurocrine Biosciences Up 7.5% Despite Q4 Miss